by Inventeur, LLC.
AIM is an intraoral bite block with pharyngeal oxygen delivery and continous capnography for procedures requiring sedation.
Non-operating room anesthesia (NORA) is the fastest-growing segment in anesthesia, but oxygen delivery and patient monitoring haven't kept pace with the increasingly complex procedures and higher-risk patients.
Limited FiO2 control. Unreliable CO2 monitoring in patients with oral breathing, most common while sedated.
Max FiO2 around 60%. Masks block airway rescue access and interfere with endoscopy and oropharyngeal procedures.
Specialized high-flow O2 equipment increases cost, complexity, and fire risk. Very limited capnography.
A single intraoral device that delivers direct pharyngeal oxygenation with integrated CO2 sampling from pre-sedation through recovery.
M. Zales, MDWith oxygen delivery comparable to the high-flow cannula, but at a fraction of the cost and without the cumbersome setup, AIM is ideal for the NORA setting.
M. Blevins, CAAI recently used AIM on a morbidly obese patient undergoing endoscopy. Despite the challenging body habitus, oxygen saturation stayed 100% throughout the procedure. The reliability in this high-risk setting was impressive and clinically reassuring.
B. DeBoard, CRNAAIM gives me the confidence to perform high-risk sedation procedures.
Todd Little, CRNAWhat impressed me the most about AIM was the speed in correcting oxygen saturation after apnea. Pharyngeal oxygenation really works. This device could be a game-changer.
K. Byju, MD, GastroenterologistWith unobtrusive access to the oral cavity, scope placement was easier. AIM prevented hypoxic episodes without any procedural interruptions.
510(k) Cleared
AIM is an FDA-cleared Class II medical device. Designed, developed, and manufactured in the United States.
With continuous EtCO2 monitoring, AIM meets the ASA sedation guidelines
As procedural complexity and patient acuity increase, AIM occupies the sweet spot: higher performance than nasal cannula, lower cost than HFNC, more versatile than face mask.
| AIM | HFNC | Nasal Cannula | Face Mask | |
|---|---|---|---|---|
| FiO2 Delivered | >96% at 14LPM | 100% at 70LPM | 30-40% | 50-60% |
| Continuous EtCO2 | Yes | Unreliable | Yes | Yes |
| Immediate Oral Access | Yes | No | No | Blocked |
| Integrated Bite Block | Yes | No | No | No |
| Setup Time | <1 min | ~5 min | <1 min | <1 min |
| MRI Safe | Yes | No | Yes | Yes |
| ASA Guideline Compliance | Full | Partial | Yes | Yes |
| O2 Equipment Required | Standard | Specialized | Standard | Standard |
| Immediate GA Conversion | Yes | No | No | No |
| Fire Risk | Low | High | Medium | Medium |
| Staff Training | Minimal | Moderate | Minimal | Minimal |
| Space Requirements | Minimal | Significant | Minimal | Minimal |
| Maintenance | None (disposable) | Regular servicing | None | None |
| Patient Comfort | High | Moderate | High | Low |
| Cost per Procedure | $$$ | $$$$$ | $$ | $$ |
Attach the oxygen supply line and CO2 sampling line to your existing equipment.
Insert the AIM bite block intraorally, just like a standard bite block.
Deliver oxygen and monitor capnography throughout the procedure with unobstructed airway access.
Maintain oxygenation and monitoring during upper and lower endoscopy procedures.
Reliable oxygen delivery during cardiac catheterization and electrophysiology procedures.
Continuous monitoring during image-guided biopsies and procedures under sedation.
Integrated bite block with oxygen delivery for dental procedures requiring sedation.
MRI Safe construction allows AIM to be used in MRI suite environments for sedated scans and interventional MRI procedures.
Consistent oxygenation and capnography across nerve blocks, spinal injections, kyphoplasty, and spinal cord stimulator implants.
Supports sedation monitoring during hysteroscopy, endometrial ablation, and D&C in ASC and office-based settings.
Reliable pharyngeal oxygenation and CO2 monitoring during IR-guided breast, tissue, and bone biopsy procedures under sedation.
NORA case volume is growing faster than any other procedural category. Every minute of airway-related interruption carries a real cost -- in time, disposables, and throughput. AIM was designed to reduce all three.
Continuous oropharyngeal oxygen delivery reduces desaturation events that force procedural pauses. Integrated capnography eliminates separate monitoring setup. Fewer device exchanges mean fewer workflow disruptions.
AIM integrates the functions of a bite block, supplemental oxygen delivery system, and capnography sampling interface into a single disposable. Fewer SKUs to order, stock, and manage.
When per-case airway setup and management time decreases -- even by minutes -- the cumulative effect across a full procedural day enables tighter scheduling and improved room utilization.
Published data estimates OR time costs at $45-60 per minute.* NORA suite costs vary by facility but follow similar economic drivers. Consider your own numbers:
| Cases per week | How many NORA cases does your facility perform weekly? |
| Minutes saved per case | If AIM eliminates even 2-3 minutes of interruption or setup time, what is the weekly total? |
| Disposables replaced | How many separate items (bite block, nasal cannula, capnography adapter) does AIM consolidate? |
| Cost per disposable set | What is your current per-case spend on those individual components? |
We encourage you to run these numbers for your facility. For a detailed analysis tailored to your case volume, contact our team.
*Macario A. "What does one minute of operating room time cost?" J Clin Anesth. 2010;22(4):233-236. Inflation-adjusted.
Common questions from clinicians and facilities evaluating AIM.
The standard nasal cannula and separate bite block delivers oxygen to the nose only, or at most also to the front of the mouth in specialty systems. Oral breathing is more common when a patient is sedated, so nasal delivery has limited FiO2 potential. Any oxygen delivered to the front of the mouth is diluted and is also limited. AIM delivers oxygen directly to the posterior pharynx from inside the mouth so FiO2 saturation can be maintained. AIM delivered greater than 96% FiO2 at 14 LPM while simultaneously providing reliable end-tidal CO2 waveforms through an integrated sampling port.
Direct pharyngeal oxygenation means oxygen is delivered from inside the oral cavity to the posterior pharynx, the anatomical space immediately above the airway opening. This enables standard oxygen flow to deliver very high FiO2 levels because it is not diluted in the mouth or nasal cavity. Mouth breathing is most common in sedated patients, so nasal delivery can be unreliable and limit maximum FiO2. Pharyngeal delivery overcomes this limitation and is particularly effective in obese patients, oral breathers, and cases where nasal airflow is compromised.
The beauty of AIM is in its simplicity! AIM is placed and connected in under one minute by any trained anesthesia provider. The workflow mirrors a standard bite block: connect the oxygen supply and CO2 sampling lines, then insert intraorally. See the IFU for full details.
AIM is FDA-cleared through the 510(k) pathway as a Class II medical device. Clinical experience includes reported SpO2 maintenance at 100% in morbidly obese patients, reliable EtCO2 waveforms across GI and cardiac procedural settings, and no procedural interference during endoscopy. Peer-reviewed publications are in progress. Contact us for our current clinical data package. [VERIFY: add any published abstracts, posters, or journal references if available]
More questions? View the full FAQ or contact our team.
Built by anesthesiologists and engineers with deep experience in clinical practice and medical device development.
Inventor & Founder, Inventeur LLC
Practicing Anesthesiologist
Professor of Anesthesiology
Neurosurgeon
CEO, Inventeur LLC
Engineer
President & CEO, Baymar Solutions
Engineer, Product Manager
VP of Engineering, Baymar Solutions
Request a sample, schedule a demo, or ask us anything.
Or email us directly at info@macmodule.com
AIM is available through the following authorized distribution partners.